Cell Therapy and Translational Medicine
Cell therapy and translational medicine are at the forefront of regenerative healthcare, focusing on the development and clinical application of living cells to treat, repair, or replace damaged tissues and restore normal biological function. This session will explore the latest advancements in cell-based therapies, including stem cell transplantation, immune cell therapies, and engineered cellular products designed for precision medicine applications. Participants will gain insights into how cells are isolated, modified, expanded, and delivered to target diseases such as cancer, cardiovascular disorders, neurological conditions, autoimmune diseases, and degenerative disorders. The session will also highlight the critical role of translational medicine in bridging laboratory discoveries with clinical practice, emphasizing preclinical studies, clinical trial design, regulatory pathways, and patient safety considerations. Discussions will cover manufacturing scalability, quality control, Good Manufacturing Practice (GMP) standards, and challenges associated with commercialization and global approval of cell-based products. Emerging technologies such as gene-edited cell therapies, CAR-T and CAR-NK cells, and combination approaches with biomaterials and drug delivery systems will also be addressed. By bringing together scientists, clinicians, regulatory experts, and industry professionals, this session aims to accelerate the translation of innovative cell therapies into safe, effective, and accessible treatments that transform modern medicine and improve patient outcomes worldwide.